Respiratory Viral Infection
45
6
9
24
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
8.9%
4 terminated out of 45 trials
85.7%
-0.8% vs benchmark
22%
10 trials in Phase 3/4
25%
6 of 24 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 24 completed trials
Clinical Trials (45)
Viral Infections and Airway Microbiome in Young Children With Cystic Fibrosis
A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Participants With Respiratory Insufficiency Expected to be Caused by Infection With Respiratory Viruses
Wells and Enteric Disease Transmission
Assessment of the Type I IFN Response in the Nasal Cavity During Respiratory Viral Infections in a Geriatric Department
Macrophage Regulation of Ozone-Induced Lung Inflammation
Study to Assess the Safety and Efficacy of ZX-7101A for Oral Suspension in Chinese Pediatric Participants 2 to 11 Years of Age With Influenza
Dime La VerDAD: Verify, Debunk, and Disseminate
Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric Patients Aged 2 to Under 12 Years With Influenza
An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
Wells and Enteric Disease Transmission Trial (WET - Trial)
Study to Assess the Safety and Efficacy of ZX-7101A in Children Aged 5-11 Years With Influenza
Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)
Study to Evaluate the Pharmacokinetics and Relative Bioavailability of Metabolites in Healthy Chinese Adult Males
Reducing Respiratory Virus Transmission in Bangladeshi Classrooms
Zinc and Green Tea Extract for Community Respiratory Viral Infections
Study to Assess the Safety and Efficacy of ZX-7101A in Adolescents With Influenza
Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)
PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT)